BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16123221)

  • 1. Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia.
    Faderl S; Do KA; Johnson MM; Keating M; O'brien S; Jilani I; Ferrajoli A; Ravandi-Kashani F; Aguilar C; Dey A; Thomas DA; Giles FJ; Kantarjian HM; Albitar M
    Blood; 2005 Dec; 106(13):4303-7. PubMed ID: 16123221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
    Melanoma Res; 2006 Oct; 16(5):405-11. PubMed ID: 17013089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival.
    Ugurel S; Rappl G; Tilgen W; Reinhold U
    J Clin Oncol; 2001 Jan; 19(2):577-83. PubMed ID: 11208853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.
    Tabone MD; Brugières L; Piperno-Neumann S; Selva MA; Marec-Bérard P; Pacquement H; Lervat C; Corradini N; Gentet JC; Couderc R; Chevance A; Mahier-Ait Oukhatar C; Entz-Werle N; Blay JY; Le Deley MC
    BMC Cancer; 2017 Jun; 17(1):419. PubMed ID: 28619014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962.
    Avramis IA; Panosyan EH; Dorey F; Holcenberg JS; Avramis VI;
    Clin Cancer Res; 2006 Dec; 12(23):6978-84. PubMed ID: 17145817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
    Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
    BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
    Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
    Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of pretreatment serum levels of VEGF and its receptors, IL- 8, and their prognostic value in type I and II endometrial cancer patients.
    Kotowicz B; Fuksiewicz M; Jonska-Gmyrek J; Berezowska A; Radziszewski J; Bidzinski M; Kowalska M
    PLoS One; 2017; 12(10):e0184576. PubMed ID: 28991928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma.
    Sharma BK; Srinivasan R; Kapil S; Singla B; Saini N; Chawla YK; Chakraborti A; Duseja A; Kalra N; Dhiman RK
    Mol Cell Biochem; 2013 Nov; 383(1-2):103-12. PubMed ID: 23912396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
    Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
    Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of angiogenic factors and their clinical significances in acute myeloid leukemia].
    Wang Y; Xiao ZJ; Liu P; Peng Z; Han ZC
    Ai Zheng; 2004 Nov; 23(11 Suppl):1423-7. PubMed ID: 15566649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic escape and angiogenesis in human malignant melanoma.
    Redondo P; Sánchez-Carpintero I; Bauzá A; Idoate M; Solano T; Mihm MC
    J Am Acad Dermatol; 2003 Aug; 49(2):255-63. PubMed ID: 12894074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M
    Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients.
    Ustuner Z; Saip P; Yasasever V; Vural B; Yazar A; Bal C; Ozturk B; Ozbek U; Topuz E
    Med Oncol; 2008; 25(4):394-9. PubMed ID: 18317954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.
    Coulon S; Francque S; Colle I; Verrijken A; Blomme B; Heindryckx F; De Munter S; Prawitt J; Caron S; Staels B; Van Vlierberghe H; Van Gaal L; Geerts A
    Cytokine; 2012 Aug; 59(2):442-9. PubMed ID: 22658783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute pyelonephritis during pregnancy changes the balance of angiogenic and anti-angiogenic factors in maternal plasma.
    Chaiworapongsa T; Romero R; Gotsch F; Kusanovic JP; Mittal P; Kim SK; Erez O; Vaisbuch E; Mazaki-Tovi S; Kim CJ; Dong Z; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2010 Feb; 23(2):167-78. PubMed ID: 20213923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients.
    Golab-Janowska M; Paczkowska E; Machalinski B; Kotlega D; Meller A; Safranow K; Wankowicz P; Nowacki P
    Curr Neurovasc Res; 2019; 16(1):19-26. PubMed ID: 30706812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
    Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endostatin variations in childhood acute lymphoblastic leukaemia--comparison with basic fibroblast growth factor and vascular endothelial growth factor.
    Schneider P; Vasse M; Corbière C; Legrand E; Marie-Cardine A; Boquet C; Cazin L; Vannier JP
    Leuk Res; 2007 May; 31(5):629-38. PubMed ID: 17011029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.